Episode 198 - October 2, 2026
02 Oct 2026AI processed
The biotech sector maintains strong year-to-date performance despite recent market choppiness and macroeconomic uncertainty, with the XBI index significantly outperforming broader benchmarks. Key industry developments include a major collaboration between Regeneron and Sanofi to extend their Dupixent lifecycle, and a s...